Cargando…
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
BACKGROUND: Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of this study is to describe the most severe co...
Autores principales: | Walasik-Szemplińska, Dorota, Kamiński, Grzegorz, Sudoł-Szopińska, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927113/ https://www.ncbi.nlm.nih.gov/pubmed/31890036 http://dx.doi.org/10.1186/s13044-019-0074-0 |
Ejemplares similares
-
A Comparison of Doppler Flow Parameters in the Ophthalmic Artery and Central Retinal Artery in Patients With Graves' Disease and Toxic Nodular Goiter
por: Walasik-Szemplińska, Dorota, et al.
Publicado: (2019) -
Doppler imaging of orbital vessels in the assessment of the activity and severity of thyroid-associated orbitopathy
por: Walasik-Szemplińska, Dorota, et al.
Publicado: (2015) -
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
por: Miśkiewicz, P., et al.
Publicado: (2018) -
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015) -
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018)